Integrating molecular point-of-care testing for influenza into primary care: a mixed-methods feasibility study

A cohort study carried out at six general practices in England suggests that point-of-care testing for influenza could have an impact on clinical prescribing practices. https://t.co/GKGhyOvVpv

RT @BJGPjournal: The benefits of molecular point-of-care testing (POCT) for flu are well known in secondary care: it is highly accurate and…

RT @BJGPjournal: The benefits of molecular point-of-care testing (POCT) for flu are well known in secondary care: it is highly accurate and…

The benefits of molecular point-of-care testing (POCT) for flu are well known in secondary care: it is highly accurate and fast. New research shows feasibility of POCT in general practice. https://t.co/1ww0jreNFj https://t.co/BVxjbSIVN5

RT @SimonBradley8: This ⬇️ is a really poor headline and promotes an action from a study that recognises its own multiple weaknesses.

RT @SimonBradley8: This ⬇️ is a really poor headline and promotes an action from a study that recognises its own multiple weaknesses.

This ⬇️ is a really poor headline and promotes an action from a study that recognises its own multiple weaknesses.

RT @BJGPjournal: "In managing influenza, antiviral treatment should ideally be started within 48 hours of the onset of symptoms. This is a…

"In managing influenza, antiviral treatment should ideally be started within 48 hours of the onset of symptoms. This is a feasibility study exploring the use of rapid molecular testing in general practice to reduce diagnostic delay." https://t.co/uKXPnGQF2

RT @BJGPjournal: Benefits of molecular point-of-care testing for flu are well known in secondary care: it is highly accurate and results ar…

Started learning from these brains in my recent new job as a SQL Developer. Six weeks in on my second project and hopefully I get to know flu, vaccine, prescription in primary care a little better in time. So pleased when the professor called me the day af

RT @BJGPjournal: Benefits of molecular point-of-care testing for flu are well known in secondary care: it is highly accurate and results ar…

RT @BJGPjournal: Benefits of molecular point-of-care testing for flu are well known in secondary care: it is highly accurate and results ar…

RT @BJGPjournal: Benefits of molecular point-of-care testing for flu are well known in secondary care: it is highly accurate and results ar…

Benefits of molecular point-of-care testing for flu are well known in secondary care: it is highly accurate and results are rapid. New research shows its feasibility in general practice. https://t.co/1ww0jreNFj https://t.co/r5INNtD6jG